
- /
- Supported exchanges
- / MU
- / AFX.MU
Carl Zeiss Meditec AG (AFX MU) stock market data APIs
Carl Zeiss Meditec AG Financial Data Overview
There is no Profile data available for AFX.MU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Carl Zeiss Meditec AG data using free add-ons & libraries
Get Carl Zeiss Meditec AG Fundamental Data
Carl Zeiss Meditec AG Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-13
- EPS/Forecast: 0.46
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Carl Zeiss Meditec AG News

ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS from Sept. 12 - 15 in Copenhagen, Denmark: EFFICIENT, CONFIDENT DECISION MAKING: introducing AI-powere...


What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?
Carl Zeiss Meditec AG (ETR:AFX), might not be a large cap stock, but it saw significant share price movement during recent months on the XTRA, rising to highs of €62.95 and falling to the lows of �...

ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
At EURETINA 2025, ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care: IMPROVE PATHOLOGY DETECTION: Now C...

ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment
Fully integrated AI decision support tool flags B scans that may require further review, supporting more confident decision making and more efficient patient care. JENA, Germany, Aug. 21, 2025 /PRNew...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.